Integrated BioPharma, Inc. is a well-established biopharma company serving the varied needs of the nutraceutical, biotech and pharmaceutical industries. Through a number of wholly owned subsidiaries INB develops, manufactures and distributes, worldwide over 130 products.
| Revenue (Most Recent Fiscal Year) | $50.32M |
| Net Income (Most Recent Fiscal Year) | $0.11M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 7.25 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.17 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.43 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 6.55 |
| Pre-Tax Margin (Trailing 12 Months) | 3.55% |
| Net Margin (Trailing 12 Months) | 2.37% |
| Return on Equity (Trailing 12 Months) | 6.36% |
| Return on Assets (Trailing 12 Months) | 4.84% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.72 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.70 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 4.36 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.66 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $0.04 |
| Exchange | NYSE |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Common Shares Outstanding | 30.92M |
| Free Float | 10.14M |
| Market Capitalization | $8.97M |
| Average Volume (Last 20 Days) | 0.02M |
| Beta (Past 60 Months) | 0.80 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 67.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 25.25% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |